Sera from 11 patients with fulminant hepatitis B were tested for antibodies to translation products of the pre-S1 and pre-S2 regions of hepatitis B virus of IgM, IgA and IgG classes, as well as of IgA1, IgA2 and SIgA, with solid-phase enzyme immunoassays using native viral polypeptides. Antibodies t
Hepatitis B pre-S1 and pre-S2 proteins: Clinical significance and relation to hepatitis B virus DNA
✍ Scribed by T. J. M. van Ditzhuijsen; L. P. C. Kuijpers; M. J. Koens; P. J. M. Rijntjes; A. M. van Loon; Dr. S. H. Yap
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 614 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Pre‐S proteins may have an important role in virus assembly and virus entry into the host cell. The presence of pre‐S proteins in serum has also been thought to correlate with active viral replication. To investigate whether pre‐S proteins in serum might have additional diagnostic and/or predictive value for liver sequelae in HBV infection, sera from six different serological groups of patients with HBV markers (total number 363) and different manifestations of liver histology were examined for the presence of pre‐S1 and pre‐S2 proteins using micro‐ELISAs. Pre‐S1 and pre‐S2 proteins were detected significantly more often in HBV‐DNA‐positive than in HBV‐DNA‐negative sera from HBsAg carriers. However, pre‐S1 and pre‐S2 proteins were also found in HBV‐DNA‐negative HBsAg carriers irrespective of serum HBeAg/anti‐HBe or liver histologic findings. These results suggest that the presence of the pre‐S1 and or pre‐S2 proteins in serum either does not seem to reflect the presence of active viral replication and active liver disease or pre‐S proteins are more readily detectable than HBeAg and HB‐DNA as measured by a dot‐blot technique. Furthermore, the presence of pre‐S proteins in serum is strongly correlated with that of HBsAg.
📜 SIMILAR VOLUMES
Hepatitis B virus (HBV) infection is the main cause of Controversial data were recently published concerning the fulminant hepatitis (FH) in several geographic areas, includassociation of hepatitis B virus (HBV) variants with fulminant ing the Mediterranean basin. 1 Traditionally the fulminant hepat
A hybrid cell line producing monoclonal antibodies recognizing an epitope encoded by the pre-(S)2 region of hepatitis B virus (HBV) genome was obtained by fusion of mouse myeloma cells with lymphocytes from mice immunized with HBV. The monoclonal antibody Mo-Fl24 secreted from the hybrid line reacte
Serial sera were collected prospectively during the clinical course of 13 HBsAg carriers with chronic liver disease and analyzed for ALT levels, pre-S, and pre-S, antigens and corresponding antibodies and other serological hepatitis B virus markers. In five patients, anti-pre-S, and anti-pre-S, anti
The peptide which is encoded by the pre-S(2) region of hepatitis B virus DNA, the pre-S(2) antigen, was determined quantitatively by an enzyme immunoassay system employing monoclonal antibodies. The prevalence and titer of pre-S(2)Ag were 91.9% (91/99) and 10,356 2 19,053 units (mean f S.D., arbitra